Gastric peroral endoscopic myotomy in refractory gastroparesis: long-term outcomes and predictive score to improve patient selection.


Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
09 2022
Historique:
received: 12 10 2021
accepted: 03 04 2022
pubmed: 13 4 2022
medline: 25 8 2022
entrez: 12 4 2022
Statut: ppublish

Résumé

Limited data exist concerning the long-term efficiency of gastric peroral endoscopic myotomy (G-POEM) as a treatment of refractory gastroparesis. This study evaluated the 3-year results of G-POEM in patients with refractory gastroparesis. This was a prospective multicenter study of all G-POEM operations performed in 2 expert French centers for 46 patients with refractory gastroparesis with at least 3 years of follow-up. Clinical success was 65.2% at 36 months. There was significant improvement in symptom severity. Median Gastroparesis Cardinal Symptom Index decreased from 3.33 to 1.80 (P < .0001), with improvement in all subscales. We created a predictive score concerning G-POEM success (G-POEM predictive score) to which points were assigned as follows: nausea subscale <2: predictive of success, 1 point; satiety subscale >4: predictive of success, 1 point; bloating subscale >3.5: predictive of success, 1 point; percentage of gastric retention at 4 hours on scintigraphy >50%: 1 point. A threshold of 2 was identified by receiver operating characteristic curve analysis with an area under the curve of .825 that predicted clinical success with a sensitivity of 93.3% (95% confidence interval [CI], .77-.99), specificity of 56.3% (95% CI, .33-.77), positive predictive value of 80% (95% CI, .67-.93), negative predictive value of 81.8% (95% CI, .59-1.00), and accuracy of 80.4% (95% CI, .69-.92). Patients with a score ≥2 were significantly more likely to be responders at 3 years than were patients with a score <2 (80% and 18%, respectively; P = .0004). The clinical success of G-POEM for refractory gastroparesis was 65.2% at 36 months. Our predictive score offers an easy tool that needs to be confirmed in other studies.

Sections du résumé

BACKGROUND AND AIMS
Limited data exist concerning the long-term efficiency of gastric peroral endoscopic myotomy (G-POEM) as a treatment of refractory gastroparesis. This study evaluated the 3-year results of G-POEM in patients with refractory gastroparesis.
METHODS
This was a prospective multicenter study of all G-POEM operations performed in 2 expert French centers for 46 patients with refractory gastroparesis with at least 3 years of follow-up.
RESULTS
Clinical success was 65.2% at 36 months. There was significant improvement in symptom severity. Median Gastroparesis Cardinal Symptom Index decreased from 3.33 to 1.80 (P < .0001), with improvement in all subscales. We created a predictive score concerning G-POEM success (G-POEM predictive score) to which points were assigned as follows: nausea subscale <2: predictive of success, 1 point; satiety subscale >4: predictive of success, 1 point; bloating subscale >3.5: predictive of success, 1 point; percentage of gastric retention at 4 hours on scintigraphy >50%: 1 point. A threshold of 2 was identified by receiver operating characteristic curve analysis with an area under the curve of .825 that predicted clinical success with a sensitivity of 93.3% (95% confidence interval [CI], .77-.99), specificity of 56.3% (95% CI, .33-.77), positive predictive value of 80% (95% CI, .67-.93), negative predictive value of 81.8% (95% CI, .59-1.00), and accuracy of 80.4% (95% CI, .69-.92). Patients with a score ≥2 were significantly more likely to be responders at 3 years than were patients with a score <2 (80% and 18%, respectively; P = .0004).
CONCLUSIONS
The clinical success of G-POEM for refractory gastroparesis was 65.2% at 36 months. Our predictive score offers an easy tool that needs to be confirmed in other studies.

Identifiants

pubmed: 35413333
pii: S0016-5107(22)00256-5
doi: 10.1016/j.gie.2022.04.002
pii:
doi:

Types de publication

Journal Article Multicenter Study Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

500-508.e2

Commentaires et corrections

Type : CommentOn
Type : CommentIn

Informations de copyright

Copyright © 2022 American Society for Gastrointestinal Endoscopy. All rights reserved.

Auteurs

Amélie Labonde (A)

Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.

Guillaume Lades (G)

Service de médecine nucléaire, CHU Limoges, Limoges, France.

Antoine Debourdeau (A)

Service d'Hépato-gastro-entérologie, CHU Montpellier, Montpellier, France.

Olivier Ragi (O)

Service d'Hépato-gastro-entérologie, CHU Lyon, Lyon, France.

Lauriane Lehmann (L)

Service d'Hépato-gastro-entérologie, Polyclinique de Limoges, Limoges, France.

Véronique Vitton (V)

Service d'Hépato-gastro-entérologie, APHM Hôpital Nord, Marseille, France.

Marc Barthet (M)

Service d'Hépato-gastro-entérologie, APHM Hôpital Nord, Marseille, France.

Romain Legros (R)

Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.

Jérémie Albouys (J)

Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.

Sophie Geyl (S)

Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.

Véronique Loustaud-Ratti (V)

Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.

Jacques Monteil (J)

Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.

Sandra Gonzalez (S)

Service de médecine nucléaire, APHM Hôpital Nord, Marseille, France.

Jean-Michel Gonzalez (JM)

Service d'Hépato-gastro-entérologie, APHM Hôpital Nord, Marseille, France.

Jérémie Jacques (J)

Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France. Electronic address: jeremie.jacques@chu-limoges.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH